Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2017-04-05

Clinical Trial Update: Impact of a Loading Dose of Caspofungin in Invasive Candidiasis in ICU Patients

View source ↗

Summary

The clinical trial evaluated the impact of a caspofungin loading dose in ICU patients with invasive candidiasis. The study status is completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Caspofungin (Cancidas) (caspofungin)

Snippet

Sponsor: Outcome Rea | Conditions: Candida Infections | Status: COMPLETED